Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors

Post time 2024-4-30 19:46:56

journal：Clinical Cancer Research

Authors：Hyung-Don Kim; Min-Hee Ryu; Young Soo Park; Changhoon Yoo; Sung-Joo Kim; Yoon-Koo Kang

Published date：--

DOI：10.1158/1078-0432.ccr-23-4065

PDF link：https://aacrjournals.org/clincan ... 945/ccr-23-4065.pdf

Article link：http://dx.doi.org/10.1158/1078-0432.ccr-23-4065

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time 2024-4-30 19:46:57

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AACR] Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 plus Imatinib for Advanced Treatment-refractory Gastrointestinal Stromal Tumors Copy